Third Party Event
by Victoria Hornikel | Oct 18, 2022
Recent Blog Postings
- New Study Highlights the Impact of Flares and Persistently Active Disease on Organ Damage in People with Systemic Lupus Erythematosus
- FDA Accepts Supplemental Biologics License Application for Gayzva for Treatment of Lupus Nephritis
- New Study Investigates the Role of microRNA-203 as a Potential Biomarker for Lupus Nephritis